COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the return of raised funds
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2014-016
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on the return of raised funds
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) held the 6th meeting of the 5th Board of Directors on October 9, 2013, and reviewed and approved the “Proposal on Temporarily Replenishing Working Capital with the Use of Partially Raised Funds” ", the company agreed to use the 40 million yuan idle raised funds to temporarily replenish the working capital, the use period is not more than 5 months, from October 10, 2013 to March 9, 2014. For details of the use of some of the idle raised funds to temporarily supplement the working capital, please refer to the “Securities Times”, “China Securities Journal”, “Shanghai Securities News”, “Securities Daily” and www.cninfo.com.cn on October 11, 2013. .cninfo.com.cn) “Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on Temporary Replenishment of Working Capital with Partial Idle Raised Funds” (2013-039).
On March 7, 2014, the company repatriated the above-mentioned temporary fund-raising funds of 40 million yuan to the fund-raising account, and the use period was less than 5 months. The company has notified the sponsor institution Northeast Securities Co., Ltd. and the sponsor representative of the return of the above raised funds.
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
March 11, 2014